Ask Warren

SLSBio(Specialty Lab Solution Bio)

246250 · KOSDAQ · ₩246250 · 에스엘에스바이오

₩1,969 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩1.3B₩958M₩341M₩296M₩1.6B₩1.8B₩1.8B₩2.1B
Cost of sales₩1.1B₩1.5B₩1.3B₩1.6B₩1.6B₩1.5B₩1.5B₩1.6B
Gross profit₩203M−₩542M−₩928M−₩1.3B₩22M₩272M₩306M₩552M
Operating income−₩898M−₩950M−₩1.4B−₩1.8B−₩674M−₩220M−₩196M₩108M
Net income−₩973M−₩939M−₩1.6B−₩2.1B−₩990M−₩199M₩175M−₩191M
Net income to shareholders−₩973M−₩939M−₩1.6B−₩2.1B−₩990M−₩199M₩175M−₩191M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩9.7B₩10B₩11B₩13B₩14B₩16B₩16B₩18B
Current assets₩3.3B₩3.6B₩4.5B₩6.2B₩8.2B₩9.5B₩9.8B₩12B
Cash and equivalents₩1.8B₩261M₩278M₩725M₩677M₩1.1B₩1.1B₩1.6B
Total liabilities₩3.9B₩3.4B₩3.6B₩3.4B₩3.3B₩3.5B₩3.8B₩3.9B
Current liabilities₩2.4B₩1.7B₩1.6B₩1.4B₩1.2B₩1.2B₩1.5B₩1.4B
Borrowings₩470M————₩0₩0—
Total equity₩5.8B₩6.7B₩7.6B₩9.2B₩11B₩12B₩13B₩14B
Shareholders' equity₩5.8B₩6.7B₩7.6B₩9.2B₩11B₩12B₩13B₩14B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩820M−₩797M−₩1.4B−₩701M−₩306M₩195M₩319M₩725M
Capital spending₩33M₩96M₩401M₩579M₩474M₩60M₩752M₩174M
Free cash flow−₩852M−₩892M−₩1.8B−₩1.3B−₩780M₩135M−₩433M₩551M
Dividends paid——————₩0₩0

Consolidated where available. Amounts in won.

Also known as: SLSBio(Specialty Lab Solution Bio) / 에스엘에스바이오 / 246250 / KRX:246250

Source: KRX statistical information